We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Humana Inc (HUM) Com Stk USD0.166

Sell:$314.47 Buy:$314.65 Change: $1.26 (0.40%)
Market closed |  Prices as at close on 15 April 2024 | Switch to live prices |
Change: $1.26 (0.40%)
Market closed |  Prices as at close on 15 April 2024 | Switch to live prices |
Change: $1.26 (0.40%)
Market closed |  Prices as at close on 15 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Humana Inc. is a healthcare company. It operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. It also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. It also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. It also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations.

Contact details

500 W Main St
United States
+1 (502) 5801000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$37.68 billion
Shares in issue:
120.55 million
Managed Health Care
New York Stock Exchange
United States
US dollar

Key personnel

  • James Rechtin
    President, Chief Operating Officer
  • Bruce Broussard
    Chief Executive Officer, Director
  • Susan Diamond
    Chief Financial Officer
  • David Dintenfass
    President - Enterprise Growth
  • George Renaudin
    President - Medicare and Medicaid
  • Sanjay Shetty
    President - CenterWell
  • John- Paul Felter
    Senior Vice President, Chief Accounting Officer, Controller
  • Timothy Huval
    Chief Administrative Officer
  • Samir Deshpande
    Chief Information Officer
  • Vishal Agrawal
    Chief Strategy and Corporate Development Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.